Display Settings:

Format

Send to:

Choose Destination

    Intern Med. 2002 Dec;41(12):1199-203.

    Anti-Ku antibody-positive scleroderma-dermatomyositis overlap syndrome developing Graves' disease and immune thrombocytopenic purpura.

    Kamei N, Yamane K, Yamashita Y, Nakanishi S, Watanabe H, Fujikawa R, Hiyama K, Ishioka S, Mendoza C, Kohno N.

    Department of Molecular and Internal Medicine, Division of Clinical Medical Science, Programs for Applied Biomedicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima.

    Comment in:

    Graves' disease (GD) has been reported to be frequently complicated with other autoimmune diseases. However, it is rarely complicated with scleroderma-polymyositis overlap syndrome. Recently, we encountered a 35-year-old woman who developed GD and immune thrombocytopenic purpura during follow-up observation of scleroderma-dermatomyositis overlap syndrome. Platelet counts recovered after high-dose gamma-globulin therapy and bolus methylprednisolone therapy. The present case is the first report of a combination of scleroderma, dermatomyositis, GD, and immune thrombocytopenic purpura. The patient was anti-Ku antibody-positive and had relatively low natural killer T cell counts, both of which might contribute to the complication of multiple autoimmune diseases.

    PMID: 12521216 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Patient drug information

    • Propylthiouracil

      Propylthiouracil is used to treat hyperthyroidism, a condition that occurs when the thyroid gland produces too much thyroid hormone. It also is taken before thyroid surgery or radioactive iodine therapy.

    • Methimazole (Tapazole®)

      Methimazole is used to treat hyperthyroidism, a condition that occurs when the thyroid gland produces too much thyroid hormone. It is also taken before thyroid surgery or radioactive iodine therapy.